The evaluation of the T cell mediated immunity in vivo (Fig. 6, S9, S10) confirmed that the production of antigen-specific (tetramer+) and active (IFN-γ+) CTLs was dose-dependent (5 mg Fe > 0.5 mg Fe), which correlates with the deceleration of tumor growth and extended survival time (Fig. S12). Here, IFNG is linked to neoplasm.